3-Bromo-2,4,6-trimethylpyridine

Catalog No. :
ACNQCO849
CAS No. :
23079-73-4
Molecular Formula :
C8H10BrN
Molecular Weight :
200.08

IUPAC Name:3-bromo-2,4,6-trimethylpyridine

3-Bromo-2,4,6-trimethylpyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$54.00Login to see priceIn stockInquiry
250mg98%$91.00Login to see priceIn stockInquiry
1g98%$243.00Login to see priceIn stockInquiry
5g98%$902.00Login to see priceIn stockInquiry
10g98%$1324.00Login to see priceIn stockInquiry
25g98%$2883.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-2,4,6-trimethylpyridine
IUPAC Name3-bromo-2,4,6-trimethylpyridine
Molecular FormulaC8H10BrN
Molecular Weight200.08
SMILESCC1=CC(C)=C(Br)C(C)=N1
InChI KeyHDIJRNSEQXUVPU-UHFFFAOYSA-N
Synonym3-Bromo-2,4,6-trimethylpyridine;3-Bromo-2,4,6-collidine;3-Bromo-2,4,6-Trimethylpyridine Hydrochloride;3-Bromo-2,4,6-Trimethylpyridine Hydrochloride(WXC04384);Pyridine, 3-bromo-2,4,6-trimethyl-
CAS No.23079-73-4
PubChem CID25136843

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACNQCO849 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTFEI452 route compound structure diagram
    ACTFEI45259229-09-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNQCO849 route product structure diagram
    ACNQCO84923079-73-4 In Stock
Inquiry

2. ACNQCO849 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNQCO849 route product structure diagram
    ACNQCO84923079-73-4 In Stock
Inquiry

Comments (0)